ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13 | -35.0% | 1,944 | 0.0% | 0.00% | – |
| Q2 2023 | $20 | +25.0% | 1,944 | 0.0% | 0.00% | – |
| Q1 2023 | $16 | -48.4% | 1,944 | 0.0% | 0.00% | – |
| Q4 2022 | $31 | -99.9% | 1,944 | 0.0% | 0.00% | – |
| Q3 2022 | $31,000 | +14.8% | 1,944 | 0.0% | 0.00% | – |
| Q2 2022 | $27,000 | -25.0% | 1,944 | 0.0% | 0.00% | – |
| Q1 2022 | $36,000 | +28.6% | 1,944 | 0.0% | 0.00% | – |
| Q4 2021 | $28,000 | -20.0% | 1,944 | 0.0% | 0.00% | – |
| Q3 2021 | $35,000 | +2.9% | 1,944 | 0.0% | 0.00% | – |
| Q2 2021 | $34,000 | -5.6% | 1,944 | -68.0% | 0.00% | – |
| Q1 2019 | $36,000 | -16.3% | 6,072 | 0.0% | 0.00% | – |
| Q4 2018 | $43,000 | -66.7% | 6,072 | +15.8% | 0.00% | – |
| Q4 2017 | $129,000 | +316.1% | 5,242 | +336.8% | 0.00% | – |
| Q3 2017 | $31,000 | -3.1% | 1,200 | 0.0% | 0.00% | – |
| Q2 2017 | $32,000 | -11.1% | 1,200 | 0.0% | 0.00% | – |
| Q1 2017 | $36,000 | +9.1% | 1,200 | 0.0% | 0.00% | – |
| Q4 2016 | $33,000 | -46.8% | 1,200 | -50.0% | 0.00% | – |
| Q3 2016 | $62,000 | +181.8% | 2,400 | +100.0% | 0.00% | – |
| Q2 2016 | $22,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 1,258,243 | $8,618,965 | 13.75% |
| Foresite Capital Management IV, LLC | 2,808,034 | $19,235,033 | 10.68% |
| Bain Capital Life Sciences Investors, LLC | 3,400,000 | $23,290,000 | 2.60% |
| GREAT POINT PARTNERS LLC | 1,691,768 | $11,588,611 | 2.11% |
| Samsara BioCapital, LLC | 696,171 | $4,768,771 | 1.46% |
| Altium Capital Management LP | 403,000 | $2,760,550 | 1.44% |
| BVF INC/IL | 7,064,736 | $48,393,442 | 1.30% |
| Aisling Capital Management LP | 434,455 | $2,976,017 | 1.23% |
| GREAT POINT PARTNERS LLC | 700,000 | $4,795,000 | 0.87% |
| VR Adviser, LLC | 1,040,754 | $7,129,165 | 0.75% |